Ignite Creation Date:
2025-12-25 @ 12:38 AM
Ignite Modification Date:
2025-12-25 @ 10:48 PM
Study NCT ID:
NCT01578967
Status:
COMPLETED
Last Update Posted:
2021-12-07
First Post:
2012-04-13
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Induction Chemo w/ABVD Followed by Brentuximab Vedotin Consolidation in Newly Diagnosed, Non-Bulky Stage I/II Hodgkin Lymphoma
Sponsor:
UNC Lineberger Comprehensive Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-04
Start Date Type:
None
Primary Completion Date:
2016-08-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-12-11
Completion Date Type:
ACTUAL
First Submit Date:
2012-04-13
First Submit QC Date:
None
Study First Post Date:
2012-04-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-09-11
Results First Submit QC Date:
None
Results First Post Date:
2017-10-12
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-11-08
Last Update Post Date:
2021-12-07
Last Update Post Date Type:
ACTUAL